The resolution proclaims February 24, 2023, as "SCN2A Day" in Arkansas to raise awareness about the SCN2A gene and its significant impact on families. SCN2A is associated with various severe neurological conditions, including early onset epilepsy, infantile spasms, and several syndromes such as Dravet Syndrome and Ohtahara Syndrome. It is also linked to intellectual disabilities and other medical issues, highlighting the importance of understanding this genetic variant for better diagnosis and treatment options.

The resolution emphasizes the need for increased awareness and education regarding SCN2A-related disorders, which can help families prepare for and manage the challenges associated with these conditions. While there is currently no cure, ongoing research is focused on developing new therapies that target the genetic abnormalities rather than just alleviating symptoms. The resolution aims to support families affected by SCN2A by providing them with essential information and resources.